MDS Podcast

Promising results on potential treatments, biomarkers, genetic predictors and more in dystonia were presented at the MDS Congress. Dr. Florence Chang highlights the key takeaways with Dr. Hugo Morales.

The lines between functional and organic are blurring, as a promising opportunity to develop outcome measurements arises. Dr. Alberto Espay discusses with Dr. Sara Schaefer these and other advancements in functional movement disorders.

Dr. Claudia Testa shares with Dr. Sara Schaefer why she believes in the quickly shifting field of tremor, we should be more open-minded about changes in diagnoses over time.

As tic cases rise, Dr. Christos Ganos overviews with Dr. Hugo Morales two major treatment advancements, a growing emphasis on neurostimulation research and multidisciplinary care, and progress in the field's largest area of opportunity.

Dr. Ron Postuma outlines with Dr. Eduardo de Pablo-Fernández several advances this year he thinks will "revolutionize" Parkinson's disease care, and shifts the field may need to make as a whole to help us reach the next phase of prodromal and personalized treatments.

Following a year of impactful neuroimaging papers, Prof. Oury Monchi discusses with Dr. Michele Matarazzo the most promising advances involving machine learning, tracers, and precision in determining imaging processes.

Shifts in the Society and the landscape of the field are set to guide growth in medical education. Dr. Veronica Santini shares insights about this new direction with Dr. Sara Schaefer and our listeners.

As genetics become more prominent in patient discussions, Professor Roy Alcalay outlines with Dr. Tiago Outeiro the key implications and opportunities as we enter "a different era of genetic testing."

Which emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro.

MDS President Francisco Cardoso shares with Dr. Michele Matarazzo the important takeaways from this year's Congress that will shape the future of movement disorders and the Society.

Despite the challenge of studying rare conditions like PSP, Dr. Yaroslau Compta discusses with Dr. Eduardo de Pablo-Fernández how leaps forward in recent advances could make us rethink the way we approach the condition.

A re-release of the episode featuring the recently-awarded "Best Review article of 2022 from the Movement Disorders journal" article, titled "The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy." Read the article.

"A Multi-Step Model of Parkinson's Disease Pathogenesis" was awarded "Best Research Article of the Movement Disorders journal for 2022." Dr. Michele Matarazzo interviews the first author, Dr. Campbell Le Heron. Read the article

Dr. Eduardo de Pablo-Fernández speaks with Dr. Dilan Athauda about his recent paper, "The impact of type 2 diabetes in Parkinson's disease" recently published in Movement Disorders . They discuss the clinical impact of type 2 diabetes in the phenotype and disease progression and the therapeutic implications of this association. Read the article.

Dr. Sara Schaefer speaks with Drs. Gregoire Courtine and Jocelyne Bloch about the use of an implanted spinal cord stimulator for the treatment of orthostatic hypotension in multiple-system atrophy. Read the article.

Dr. Hilmar Sigurdsson shares the results of an FDG PET study that found 2 distinct patterns of brain metabolism related to gait disfunction in PD, suggesting that this objective measure could help better understand the neural basis of gait disorders and could also be used to predict gait involvement in clinical practice and as outcome measure in clinical trials. Read the article.

In the last episode focused on peer reviews, Dr. Michael Okun discusses historical perspectives and future directions of the peer review process.

Dr. Eduardo de Pablo-Fernández interviews Dr. Iva Stankovic and Prof. Gregor Wenning on the newly published MDS Criteria for the Diagnosis of Multiple System Atrophy. Read the article. Journal CME will be available for this article until June 17, 2023.

Dr. Sara Schaefer and Dr. Georgia Richard discuss the breakdown in medication prescribing and administration in hospitalized Parkinson's patients, and potential strategies for improvement. Read the article.

In this episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Jose Obeso to discuss some points on how NOT to conduct a peer review.

In this episode we interviewed Prof. Veerle Baekelandt from KU Leuven, Belgium, who was the main organizer of the Synuclein Meeting 2022. We discussed the major highlights of the meeting, what to expect in the coming years, and what are the major questions still to be addressed.

For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Prof. Claudia Trenkwalder about the ethics of peer review.

Dr. Hugo Morales interviews Dr. Chen Honglei about his most recent paper "High Pesticide Exposure Events and Dream-Enacting Behaviors Among US Farmers" published in the Movement Disorders journal. Read the article. Journal CME will be available for this article until May 20, 2023.

For this episode of the special series focused on peer reviews, Dr. Daniel Di Luca speaks with Prof. Marcelo Merello about the role of young members and trainees in the peer review process.

Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in Movement Disorders . Read the article.